Christine Simmon

Executive Vice President, Policy and Strategic Alliances
Executive Director, Biosimilars Council

Association for Accessible Medicines

Tue., February 15 | 10:00 a.m.

Leveraging Biosimilars Competition for Success

Christine Simmon joined the Association for Accessible Medicines (AAM) in 2012 and is the Executive Vice President, Policy and Strategic Alliances. Christine also serves as Executive Director of the Biosimilars Council, the AAM subsidiary that advocates for greater access for patients to biosimilar medicines.

In her current role, Christine is responsible for leading policy development and issues management for AAM, directing the Biosimilars Council, and building relationships with strategic partners in the health care sector, including patient advocacy groups.

Christine had previously served as Vice President of Policy, Public Affairs & Development at AAM from 2002 to 2006 and Senior Vice President of Policy & Strategic Alliances from 2012 to 2021. Before rejoining the association, she was the Senior Director of Public Policy for CVS Caremark, where she was the policy lead for the integrated retail, convenient care clinic and pharmacy benefit manager enterprise at both the state and federal levels. Previously, Christine was a Senior Policy Analyst at BlueCross BlueShield Association, where she helped position the insurer as a leading voice on pharmaceutical cost and safety issues.

Christine received her J.D. from Georgetown University Law Center and her B.A. in American Studies from Georgetown University.